Ai‐Wu Ke

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma.
  2025 L1 66/100

1 assessed by us (0 reproduced) · 183 not yet assessed — every PubMed paper on record, linked below.

• The PON1-NDUFA4 axis maintains mitochondrial respiratory fitness and drives lenvatinib tolerance in hepatocellular carcinoma ↗

  Molecular Cancer Research · 2026 · PMID 42518245
  not yet assessed
• CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma ↗

  Cell Reports Medicine · 2025 · PMID 40592346
  not yet assessed
• Lysine‐specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti‐programmed death 1 therapy in liver cancer ↗

  Clinical and Translational Medicine · 2025 · PMID 40356247
  not yet assessed
• Cordycepin mediates pyroptosis in HCC through the upregulation of TXNIP and synergizes with anti–PD-L1 immunotherapy ↗

  Hepatology Communications · 2025 · PMID 40008893
  not yet assessed
• Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma

  Nature Communications · 2025 · PMID 41387425
  L1 66/100
• The MASTL/YBX1/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib resistance and tumor progression in HCC ↗

  Hepatology · 2025 · PMID 40456026
  not yet assessed
• Targeting MORF4L1-mediated DNA repair potentiates RT-induced antitumor immunity via cGAS-STING activation in hepatocellular carcinoma ↗

  Cellular and Molecular Immunology · 2025 · PMID 41188483
  not yet assessed
• Erratum: CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma ↗

  Hepatology · 2025 · PMID 39960205
  not yet assessed
• Detecting ectopic thymus in thymoma-associated myasthenia gravis through flow cytometry analysis of CD3mediumTCRvβmediumCD4+CD8+ T cells and its clinical significance ↗

  Annals of Medicine and Surgery · 2025 · PMID 40110256
  not yet assessed
• Erratum: Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor–induced epithelial-mesenchymal transition ↗

  Hepatology · 2025 · PMID 39964298
  not yet assessed
• IL-8+ Naïve T Cells as a Biomarker for Thymoma Diagnosis: A Prospective Multi-Center Study on Diagnostic Accuracy ↗

  SSRN Electronic Journal · 2025
  not yet assessed
• Erratum: Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition ↗

  Hepatology · 2025 · PMID 40194300
  not yet assessed
• Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis ↗

  Cancer Biology and Medicine · 2025 · PMID 40269559
  not yet assessed
• Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma ↗

  Nature Communications · 2024 · PMID 38245530
  not yet assessed
• Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway ↗

  Pharmacological Research · 2024 · PMID 38280440
  not yet assessed
• Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors ↗

  Radiotherapy and Oncology · 2024 · PMID 38997092
  not yet assessed
• Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1/2 axis in hepatocellular carcinoma ↗

  International Journal of Biological Sciences · 2024 · PMID 38993552
  not yet assessed
• Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors ↗

  Journal of Translational Medicine · 2024 · PMID 39354613
  not yet assessed
• Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis ↗

  Molecular Cancer · 2024 · PMID 38424621
  not yet assessed
• The Role of Translation Initiation Regulation in Tumorigenesis, Progression and Drug Resistance ↗

  Journal of Biomedical Research & Environmental Sciences · 2024
  not yet assessed
• PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy ↗

  Advanced Science · 2023 · PMID 37705495
  not yet assessed
• Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis ↗

  Cell Death and Disease · 2023 · PMID 36732324
  not yet assessed
• WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas ↗

  Cancer Letters · 2023 · PMID 37279851
  not yet assessed
• Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment ↗

  Biomedicine & Pharmacotherapy · 2023 · PMID 36940618
  not yet assessed
• Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy ↗

  Cancer Letters · 2023 · PMID 37105392
  not yet assessed
• Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma ↗

  International Immunopharmacology · 2023 · PMID 37494837
  not yet assessed
• Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma ↗

  Frontiers in Oncology · 2023 · PMID 37593098
  not yet assessed
• Cancer-derived exosomal circTMEM56 sensitize HCC radiotherapy by augment cGAS-STING pathway in dendritic cells ↗

  Research Square · 2023
  not yet assessed
• Data from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure Legend from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Tables 1-3 from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Data from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure Legend from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Tables 1-3 from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Data from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Tables 1-2 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Supplementary Figure Legend from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Data from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Data from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Supplementary Figure 2 from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Figure 2 from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Tables 1-2 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Data from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Supplementary Figure Legend from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  2023
  not yet assessed
• Data from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Figure Legends 1-2, Tables 1-4 from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Figure Legends 1-2, Tables 1-4 from Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  2023
  not yet assessed
• Supplementary Figures and methods from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S2 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S7 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S6 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S5 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S3 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S1 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S4 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Supplementary Figure 2 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 4 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 3 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure Legend, Tables 1 - 2 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Table S2 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S1 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S4 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Supplementary Figures and methods from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S6 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S3 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S7 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Table S5 from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Supplementary Figure 1 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure Legend, Tables 1 - 2 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 2 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 3 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Supplementary Figure 4 from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Data from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Data from Margin-Infiltrating CD20<sup>+</sup> B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  2023
  not yet assessed
• Application of a Single-Cell-RNA-Based Biological-Plausible Graph Neural Network in Diagnosis of Primary Liver Tumours ↗

  SSRN Electronic Journal · 2023
  not yet assessed
• Data from Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  2023
  not yet assessed
• Current applications and future perspective of CRISPR/Cas9 gene editing in cancer ↗

  Molecular Cancer · 2022 · PMID 35189910
  not yet assessed
• Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma ↗

  Nature Communications · 2022 · PMID 35347134
  not yet assessed
• PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma ↗

  Journal of Hepatology · 2022 · PMID 35219791
  not yet assessed
• Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma ↗

  Gut Microbes · 2022 · PMID 36563106
  not yet assessed
• Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway ↗

  Journal of Experimental & Clinical Cancer Research · 2022 · PMID 35986343
  not yet assessed
• Ferroptosis and its interaction with tumor immune microenvironment in liver cancer ↗

  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2022 · PMID 36502929
  not yet assessed
• Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma ↗

  Hepatology · 2022 · PMID 35243663
  not yet assessed
• The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion ↗

  Hepatology International · 2022 · PMID 36418844
  not yet assessed
• KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma ↗

  Cancer Cell International · 2022 · PMID 35305624
  not yet assessed
• Circular RNA circEIF3C promotes intrahepatic cholangiocarcinoma progression and immune evasion via the miR-34a-5p/B7–H4 axis ↗

  Genes & Diseases · 2022 · PMID 37223528
  not yet assessed
• KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma ↗

  Biomarker Research · 2022 · PMID 35468812
  not yet assessed
• Publisher Correction: Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma ↗

  Nature Communications · 2022 · PMID 35581192
  not yet assessed
• Corrigendum to: “PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma” [J Hepatol 77 (2022) 163-176] ↗

  Journal of Hepatology · 2022 · PMID 36564318
  not yet assessed
• Molecular Features and Clinical Implications of Perineural Invasion in Intrahepatic Cholangiocarcinoma ↗

  SSRN Electronic Journal · 2022
  not yet assessed
• Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma ↗

  Journal of Hematology & Oncology · 2021 · PMID 34838121
  not yet assessed
• CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity ↗

  Molecular Cancer · 2021 · PMID 33985545
  not yet assessed
• The progress of immune checkpoint therapy in primary liver cancer ↗

  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2021 · PMID 34688805
  not yet assessed
• CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma ↗

  Frontiers in Immunology · 2021 · PMID 34526987
  not yet assessed
• Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B‐related hepatocellular carcinoma ↗

  Clinical and Translational Medicine · 2021 · PMID 33783990
  not yet assessed
• The influence of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma ↗

  HepatoBiliary Surgery and Nutrition · 2021 · PMID 36268256
  not yet assessed
• Single-Cell Transcriptomic Analysis Reveals Two Molecularly and Clinically Distinct Subtypes of Intrahepatic Cholangiocarcinoma ↗

  Research Square · 2021
  not yet assessed
• Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis ↗

  Molecular Cancer · 2020 · PMID 32430013
  not yet assessed
• Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning ↗

  Gut · 2020 · PMID 32998878
  not yet assessed
• Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression ↗

  Cell Discovery · 2020 · PMID 33298893
  not yet assessed
• miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop ↗

  Theranostics · 2020 · PMID 32206115
  not yet assessed
• GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma ↗

  Bioengineered · 2020 · PMID 33258389
  not yet assessed
• Interleukin-8 as a candidate for thymoma identification and recurrence surveillance ↗

  Nature Communications · 2020 · PMID 32985506
  not yet assessed
• MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma ↗

  Journal of Cancer · 2020 · PMID 32201518
  not yet assessed
• Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• Additional file 2 of Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis ↗

  Open MIND · 2020
  not yet assessed
• Additional file 3 of Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis ↗

  Figshare · 2020
  not yet assessed
• <p>RNF128 Promotes Malignant Behaviors via EGFR/MEK/ERK Pathway in Hepatocellular Carcinoma</p> ↗

  OncoTargets and Therapy · 2020 · PMID 33116595
  not yet assessed
• Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma ↗

  Gut · 2019 · PMID 31358576
  not yet assessed
• Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors ↗

  Theranostics · 2019 · PMID 31367249
  not yet assessed
• Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma ↗

  Journal of Experimental & Clinical Cancer Research · 2019 · PMID 30836988
  not yet assessed
• Lymphoid‐specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression ↗

  Cancer Science · 2019 · PMID 31066149
  not yet assessed
• Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance ↗

  Molecular Medicine Reports · 2019 · PMID 31257527
  not yet assessed
• Predicting overall survival of patients with hepatocellular carcinoma using a three‐category method based on DNA methylation and machine learning ↗

  Journal of Cellular and Molecular Medicine · 2019 · PMID 30784182
  not yet assessed
• eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation. ↗

  PubMed · 2019 · PMID 31218114
  not yet assessed
• Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma ↗

  Journal of Cancer · 2019 · PMID 31772652
  not yet assessed
• Additional file 3: of Circular RNA circTRIM33â 12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression ↗

  INDIGO (University of Illinois at Chicago) · 2019
  not yet assessed
• Additional file 7: of Circular RNA circTRIM33â 12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression ↗

  Figshare · 2019
  not yet assessed
• Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing ↗

  Cell Research · 2018 · PMID 29327728
  not yet assessed
• CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma ↗

  Hepatology · 2018 · PMID 30070719
  not yet assessed
• Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma ↗

  Journal of Hepatology · 2018 · PMID 29551704
  not yet assessed
• Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult ↗

  Cancer Research · 2018 · PMID 30065049
  not yet assessed
• Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma ↗

  Theranostics · 2018 · PMID 30555574
  not yet assessed
• The long noncoding RNA NORAD enhances the TGF‐β pathway to promote hepatocellular carcinoma progression by targeting miR‐202‐5p ↗

  Journal of Cellular Physiology · 2018 · PMID 30537113
  not yet assessed
• 5-Hydroxymethylcytosines from Circulating Cell-free DNA as Diagnostic and Prognostic Markers for Hepatocellular Carcinoma ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma ↗

  Cell Death and Disease · 2017 · PMID 29235470
  not yet assessed
• Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis ↗

  Journal of Cancer · 2017 · PMID 29151974
  not yet assessed
• Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro ↗

  Journal of Clinical Pathology · 2017 · PMID 28096273
  not yet assessed
• Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma ↗

  The Journal of Pathology · 2017 · PMID 28833123
  not yet assessed
• Whole-Exome Sequencing-Based Mutational Profiling of Hepatitis B Virus-Related Early-Stage Hepatocellular Carcinoma ↗

  Gastroenterology Research and Practice · 2017 · PMID 29333154
  not yet assessed
• Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling ↗

  Cell Death and Disease · 2016 · PMID 27100895
  not yet assessed
• UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2 ↗

  Oncotarget · 2016 · PMID 27121050
  not yet assessed
• Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC ↗

  Oncotarget · 2016 · PMID 26756217
  not yet assessed
• Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance ↗

  Tumor Biology · 2016 · PMID 26801674
  not yet assessed
• BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma ↗

  International Journal of Immunopathology and Pharmacology · 2015 · PMID 25816404
  not yet assessed
• Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor–induced epithelial‐mesenchymal transition ↗

  Hepatology · 2015 · PMID 25998839
  not yet assessed
• Mitogen‐activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial‐mesenchymal transition ↗

  Hepatology · 2015 · PMID 26340507
  not yet assessed
• Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity ↗

  Oncotarget · 2015 · PMID 26672766
  not yet assessed
• Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis. ↗

  PubMed · 2015 · PMID 25628953
  not yet assessed
• Generation of stable GFP-LC3 expressing HCC cell line. ↗

  Figshare · 2015
  not yet assessed
• 高血压患者血清胱抑素 C 与颈动脉粥样硬化的相关性研究

  心脑血管病防治 · 2015
  not yet assessed
• Ubiquitin‐specific protease 7 accelerates p14ARF degradation by deubiquitinating thyroid hormone receptor‐interacting protein 12 and promotes hepatocellular carcinoma progression ↗

  Hepatology · 2014 · PMID 25557975
  not yet assessed
• Activating Mutations in PTPN3 Promote Cholangiocarcinoma Cell Proliferation and Migration and Are Associated With Tumor Recurrence in Patients ↗

  Gastroenterology · 2014 · PMID 24503127
  not yet assessed
• MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells ↗

  Scientific Reports · 2014 · PMID 25027009
  not yet assessed
• Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing ↗

  Hepatology · 2014 · PMID 24425307
  not yet assessed
• Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma ↗

  Tumor Biology · 2014 · PMID 25480415
  not yet assessed
• <scp>CC</scp> chemokine receptor‐like 1 functions as a tumour suppressor by impairing <scp>CCR7</scp>‐related chemotaxis in hepatocellular carcinoma ↗

  The Journal of Pathology · 2014 · PMID 25255875
  not yet assessed
• Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients ↗

  PLoS ONE · 2014 · PMID 24816558
  not yet assessed
• Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications ↗

  Tumor Biology · 2014 · PMID 25391422
  not yet assessed
• Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma ↗

  Oncology Letters · 2014 · PMID 24520286
  not yet assessed
• Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells ↗

  Autophagy · 2013 · PMID 24157892
  not yet assessed
• Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma ↗

  Clinical Cancer Research · 2013 · PMID 24056784
  not yet assessed
• αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma ↗

  Hepatology · 2013 · PMID 23316005
  not yet assessed
• Promoting Colonization in Metastatic HCC Cells by Modulation of Autophagy ↗

  PLoS ONE · 2013 · PMID 24058558
  not yet assessed
• Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma ↗

  PLoS ONE · 2013 · PMID 23349941
  not yet assessed
• Genetic Polymorphism of the Kinesin-Like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma ↗

  PLoS ONE · 2013 · PMID 23634229
  not yet assessed
• Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma ↗

  PLoS ONE · 2012 · PMID 22428038
  not yet assessed
• Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection ↗

  PLoS ONE · 2012 · PMID 22427881
  not yet assessed
• Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis ↗

  Autophagy · 2011 · PMID 21691147
  not yet assessed
• CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC Cells ↗

  Gastroenterology · 2011 · PMID 21320503
  not yet assessed
• Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation ↗

  Clinical Cancer Research · 2011 · PMID 21825039
  not yet assessed
• Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition ↗

  Clinical Cancer Research · 2011 · PMID 21976539
  not yet assessed
• Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer ↗

  PLoS ONE · 2011 · PMID 22110720
  not yet assessed
• Resveratrol Inhibits Proliferation and Induces Apoptosis through the Hedgehog Signaling Pathway in Pancreatic Cancer Cell ↗

  Pancreatology · 2011 · PMID 22301921
  not yet assessed
• Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin β1 Complex in the Progression of Hepatocellular Carcinoma ↗

  PLoS ONE · 2011 · PMID 21961047
  not yet assessed
• Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer ↗

  PLoS ONE · 2011 · PMID 21494603
  not yet assessed
• Correction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer ↗

  PLoS ONE · 2011
  not yet assessed
• CD151 Modulates Expression of Matrix Metalloproteinase 9 and Promotes Neoangiogenesis and Progression of Hepatocellular Carcinoma ↗

  Hepatology · 2010 · PMID 20578262
  not yet assessed
• Up-regulation of Krüppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma ↗

  Gastroenterology · 2010 · PMID 20728449
  not yet assessed
• Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients ↗

  Cancer · 2010 · PMID 20715158
  not yet assessed
• Inactivation of Kupffer Cells by Gadolinium Chloride Protects Murine Liver From Radiation-Induced Apoptosis ↗

  International Journal of Radiation Oncology*Biology*Physics · 2010 · PMID 20206021
  not yet assessed
• Liver‐intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus‐positive hepatocellular carcinoma ↗

  Cancer · 2009 · PMID 19626651
  not yet assessed
• Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma ↗

  Cancer Research · 2008 · PMID 19010888
  not yet assessed
• Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma # ↗

  Hepatology · 2008 · PMID 19065669
  not yet assessed
• Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials ↗

  Journal of Cancer Research and Clinical Oncology · 2008 · PMID 18470535
  not yet assessed
• [Expression of plexinB1 in different liver cell lines and in hepatocarcinoma tissues]. ↗

  PubMed · 2008 · PMID 18983780
  not yet assessed
• [Clinical significance of the over-expression of tetraspanin CD151 in hepatocellular carcinomas]. ↗

  PubMed · 2008 · PMID 18423162
  not yet assessed